Scientists probe why kids get better flu protection from nasal spray
NCT ID NCT06501963
Summary
This study aimed to understand why the nasal spray flu vaccine provides strong, lasting protection in children but is less effective and shorter-lasting in adults. Researchers enrolled 51 healthy adults (ages 18-49) who received the FDA-approved nasal spray vaccine and provided blood and nasal samples over one month. By comparing immune responses, the goal was to gather knowledge that could help design better flu vaccines for everyone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.